IRIS
MALCOVATI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.266
AS - Asia 6.266
EU - Europa 4.272
SA - Sud America 1.041
Continente sconosciuto - Info sul continente non disponibili 512
AF - Africa 196
OC - Oceania 19
Totale 22.572
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.860
CN - Cina 2.701
SG - Singapore 1.436
HK - Hong Kong 882
IE - Irlanda 873
BR - Brasile 797
IT - Italia 635
VN - Vietnam 566
RU - Federazione Russa 454
UA - Ucraina 439
FI - Finlandia 428
DE - Germania 426
FR - Francia 286
GB - Regno Unito 250
SE - Svezia 194
CA - Canada 165
IN - India 129
BD - Bangladesh 92
AR - Argentina 79
MX - Messico 71
ZA - Sudafrica 68
JP - Giappone 65
NL - Olanda 59
IQ - Iraq 55
TR - Turchia 48
AT - Austria 42
CO - Colombia 36
EC - Ecuador 34
ES - Italia 34
PL - Polonia 34
PK - Pakistan 33
VE - Venezuela 31
CR - Costa Rica 30
ID - Indonesia 29
UZ - Uzbekistan 26
BE - Belgio 24
SA - Arabia Saudita 24
KE - Kenya 21
IL - Israele 20
JM - Giamaica 20
CL - Cile 18
PH - Filippine 18
SV - El Salvador 18
TN - Tunisia 18
MY - Malesia 17
NI - Nicaragua 17
PY - Paraguay 17
AU - Australia 15
GT - Guatemala 15
HN - Honduras 15
JO - Giordania 13
MA - Marocco 13
PE - Perù 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
TT - Trinidad e Tobago 12
CZ - Repubblica Ceca 11
KR - Corea 11
LT - Lituania 11
EU - Europa 10
NG - Nigeria 10
DZ - Algeria 9
EE - Estonia 9
EG - Egitto 9
NP - Nepal 9
PR - Porto Rico 9
BO - Bolivia 8
KZ - Kazakistan 8
MU - Mauritius 8
CH - Svizzera 7
ET - Etiopia 7
GP - Guadalupe 7
KG - Kirghizistan 7
LB - Libano 7
OM - Oman 7
AL - Albania 6
DK - Danimarca 6
PS - Palestinian Territory 6
RS - Serbia 6
AO - Angola 5
CW - ???statistics.table.value.countryCode.CW??? 5
DO - Repubblica Dominicana 5
IR - Iran 5
PA - Panama 5
RO - Romania 5
UY - Uruguay 5
AM - Armenia 4
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
GR - Grecia 4
HU - Ungheria 4
LV - Lettonia 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
GD - Grenada 3
GH - Ghana 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
Totale 22.013
Salva come PNG Salva come JPEG
Città #
San Jose 1.163
Chandler 911
Hong Kong 871
Dublin 869
Ashburn 831
Singapore 735
Dallas 620
Council Bluffs 608
Jacksonville 589
Nanjing 524
Beijing 391
Boardman 381
Los Angeles 216
Lauterbourg 211
Princeton 210
Ho Chi Minh City 200
Lawrence 197
Nanchang 197
New York 191
Medford 188
Wilmington 172
Changsha 154
Hebei 145
Shenyang 138
Hanoi 137
Santa Clara 120
Buffalo 119
Jiaxing 119
Helsinki 115
Milan 114
Redondo Beach 90
Tianjin 89
Ann Arbor 84
Hangzhou 80
Shanghai 78
Moscow 77
Munich 72
São Paulo 69
Pavia 66
The Dalles 60
Columbus 56
Seattle 55
Tokyo 53
Orem 50
Nuremberg 49
Chicago 47
San Francisco 45
Rome 42
Toronto 42
Brooklyn 41
Woodbridge 39
Atlanta 38
Frankfurt am Main 38
Johannesburg 38
Phoenix 38
Montreal 37
Denver 36
Norwalk 35
Turku 35
Washington 34
Warsaw 33
Belo Horizonte 30
Haiphong 30
North Bergen 30
Da Nang 28
Chennai 27
London 26
Brussels 24
Mexico City 24
Boston 23
San José 23
Brasília 22
Fairfield 22
Guangzhou 22
Verona 22
Naples 21
Houston 20
Jinan 20
Nairobi 20
Tashkent 20
Amsterdam 19
Rio de Janeiro 19
Zhengzhou 18
Charlotte 17
Falls Church 17
Managua 17
Baghdad 16
Poplar 16
San Salvador 16
Bogotá 15
Des Moines 15
Stockholm 15
Ankara 14
Kunming 14
Las Vegas 14
Vienna 14
Istanbul 13
Kingston 13
Amman 12
Falkenstein 12
Totale 13.842
Salva come PNG Salva come JPEG
Nome #
A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data 183
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 169
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 159
A rule-based expert system for automatic implementation of somatic variant clinical interpretation guidelines 158
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 156
ANALYSIS OF THE MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 154
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 153
A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes 153
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms 152
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia 151
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 150
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts 149
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 140
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. 138
Classification and prognostic evaluation of myelodysplastic syndromes 138
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome 137
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 136
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 134
Circulating endothelial cell separation from peripheral blood of patients affected by myelodysplastic syndromes: Preliminary results obtained by a new immunomagnetic procedure 134
Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2. 132
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. 128
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 127
Clinical significance of somatic mutation in unexplained blood cytopenia 127
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 126
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 126
Revised international prognostic scoring system for myelodysplastic syndromes 125
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. 123
Pan-cancer analysis of whole genomes 122
Hematologic passport for athletes competing in endurance sports: a feasibility study. 121
Somatic mutations of calreticulin in myeloproliferative neoplasms 121
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes 120
Clinical and biological implications of driver mutations in myelodysplastic syndromes 120
Myelodysplastic syndromes: diagnosis and staging. 119
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 118
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. 118
CHARACTERIZATION OF A CELLULAR MODEL FOR THE STUDY OF MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 118
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. 118
Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools. 118
Relationship between clone metrics and clinical outcome in clonal cytopenia 116
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. 116
Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010. 116
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 116
Myelodysplastic syndromes--coping with ineffective hematopoiesis. 115
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. 115
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System. 114
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome 113
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. 111
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 110
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 109
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 109
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. 109
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 108
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications 108
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms 107
Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes 106
VASCULAR ENDOTHELIAL GROWTH FACTOR OVEREXPRESSION IN BONE MARROW CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME: BIOLOGICAL AND CLINICAL RELEVANCE 106
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. 106
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. 106
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 106
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia 106
Peripheral arterial vascular function at altitude: sea-level natives versus Himalayan high-altitude natives 105
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome 105
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors. 105
Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms. 105
Appreci8: A pipeline for precise variant calling integrating 8 tools 105
Disclosing the impact of carcinogenic SF3b mutations on pre-mRNA recognition via all-atom simulations 105
Myelodysplastic/myeloproliferative disorders 104
Clinical significance of genetic aberrations in secondary acute myeloid leukemia. 104
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. 104
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts 103
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 102
ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing 101
Atomic-Level Mechanism of Pre-mRNA Splicing in Health and Disease 101
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 100
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes 100
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms 100
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome 100
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. 99
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 99
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging. 98
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective 98
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 97
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications 97
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications 96
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. 96
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 96
Genetic and clinical heterogeneity of ferroportin disease. 96
Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes. 95
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes 95
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. 95
Myelodysplastic/myeloproliferative neoplasms 95
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. 95
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 95
Simian virus 40 and lymphoproliferative disorder. 94
THE IMPACT OF THE DEGREE OF ANEMIA ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME. A BASIS FOR PROGNOSTIC ASSESSMENT AND CLINICAL DECISION MAKING 94
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes 93
Myelodysplastic syndromes with bone marrow fibrosis. 92
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM) 92
GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome 92
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance. 92
Totale 11.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022883 0 0 0 15 34 34 12 42 57 34 143 512
2022/20232.553 272 138 20 234 248 264 2 165 1.050 25 96 39
2023/20241.160 85 199 58 78 113 327 29 69 10 23 78 91
2024/20253.174 75 286 106 84 72 195 203 228 653 170 366 736
2025/20268.000 544 693 909 919 866 320 1.612 343 644 610 325 215
2026/20272.688 191 641 638 1.218 0 0 0 0 0 0 0 0
Totale 22.572